Anika Therapeutics, Inc.
Anika Therapeutics, Inc. scores highest on Nitro (89) and lowest on Price (29). Its PosiPenta is 64.30 out of 100, better than most similar companies.
On the Penta Grid this week, Anika Therapeutics, Inc. is Grid #74 of 837 in the Healthcare sector in United States, and Grid #256 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Anika Therapeutics, Inc. | 64.30 | 29 | 83 | 89 | 59 | 61 |
| ClearPoint Neuro, Inc. | 23.73 | 2 | 34 | 28 | 9 | 46 |
| InfuSystem Holdings, Inc. | 58.99 | 33 | 61 | 95 | 60 | 45 |
| Fulcrum Therapeutics, Inc. | 43.88 | 40 | 52 | 27 | 65 | 35 |
| Vogenx, Inc. | 48.79 | 0 | 70 | 33 | 95 | 45 |
| Century Therapeutics, Inc. | 47.01 | 39 | 54 | 51 | 47 | 44 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -86.87 |
| P/B ratio | 1.95 |
EEarnings
| Trailing EPS | ₹-21.78 |
| Forward EPS | ₹89.98 |
NNitro
| Price | 1892.40 |
| 52-week high | 2167.08 |
| 52-week low | 821.18 |
| Fall from 52-week high | 12.7% |
TTorque
| Return on equity (ROE) | -2.19% |
| Debt-to-equity | 0.18 |
AAnchor
| Beta (price swings) | 0.21 |
| Market cap | ₹2,532 Cr |
| Insider holding | 6.40% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Anika Therapeutics, Inc.'s PosiPenta score?
Anika Therapeutics, Inc.'s PosiPenta is 64.30 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Anika Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Anika Therapeutics, Inc. is Grid #74 of 837 in the Healthcare sector in United States, and Grid #256 of 4,000 in United States.
Which PosiPenta pillar is strongest for Anika Therapeutics, Inc.?
Nitro (momentum), with a score of 89 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Anika Therapeutics, Inc.?
Price (valuation), with a score of 29 out of 100: weaker than most similar companies.
Has Anika Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.34 points, from 62.96 to 64.30.
PositoAI is for research and education only and is not investment advice.